News
This fall, it may not be possible for many parents to have a healthy child younger than age 5 immunized against COVID.
Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...
Pfizer (PFE) stock and BioNTech (BNTX) stock in focus as FDA may not renew the authorization for their pediatric COVID shot. Read more here.
The Food and Drug Administration is considering revoking Pfizer Inc.’s authorization to sell its Covid vaccine for children under the age of 5, a move that would leave healthy kids with no available ...
Those who invested in Pfizer three years ago and hung on are not thrilled. They would have done much better with a simple S&P ...
4hon MSN
The top public health officials during Trump's first term praised mRNA vaccines. In the second term, officials seem to be retreating from them.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results